These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16572896)
1. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs. Pesic M; Markovic JZ; Jankovic D; Kanazir S; Markovic ID; Rakic L; Ruzdijic S J Chemother; 2006 Feb; 18(1):66-73. PubMed ID: 16572896 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R). Andjelkovic T; Pesic M; Bankovic J; Tanic N; Markovic ID; Ruzdijic S Cancer Biol Ther; 2008 Jul; 7(7):1024-32. PubMed ID: 18414057 [TBL] [Abstract][Full Text] [Related]
3. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance. Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers. Chen YL; Yang TY; Chen KC; Wu CL; Hsu SL; Hsueh CM Cell Oncol (Dordr); 2016 Oct; 39(5):411-433. PubMed ID: 27306525 [TBL] [Abstract][Full Text] [Related]
5. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R). Pesić M; Andjelković T; Banković J; Marković ID; Rakić L; Ruzdijić S Invest New Drugs; 2009 Apr; 27(2):99-110. PubMed ID: 18493718 [TBL] [Abstract][Full Text] [Related]
6. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var. Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681 [TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line. Chu JJ; Chiang CD; Rao CS; Chang WM; Lai YK Anticancer Res; 2000; 20(4):2449-56. PubMed ID: 10953309 [TBL] [Abstract][Full Text] [Related]
8. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil. Pesić M; Podolski A; Rakić L; Ruzdijić S Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022 [TBL] [Abstract][Full Text] [Related]
9. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? Merk J; Rolff J; Dorn C; Leschber G; Fichtner I Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313 [TBL] [Abstract][Full Text] [Related]
10. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361 [TBL] [Abstract][Full Text] [Related]
11. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041 [TBL] [Abstract][Full Text] [Related]
12. [Relationship between the acquired multi-drug resistance of human large cell lung cancer cell line NCI-H460 by cisplatin selection and p53 mutation]. Wang T; Xu J; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):102-7. PubMed ID: 15854392 [TBL] [Abstract][Full Text] [Related]
13. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572 [TBL] [Abstract][Full Text] [Related]
15. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342 [TBL] [Abstract][Full Text] [Related]
17. [Expression of multidrug resistance-associated protein gene in non-small cell lung cancer]. Xu M; Li J; Xia Q Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):268-70. PubMed ID: 11775850 [TBL] [Abstract][Full Text] [Related]
18. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. Lee E; Lim SJ Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971 [TBL] [Abstract][Full Text] [Related]
19. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice. Kraus-Berthier L; Jan M; Guilbaud N; Naze M; Pierré A; Atassi G Clin Cancer Res; 2000 Jan; 6(1):297-304. PubMed ID: 10656461 [TBL] [Abstract][Full Text] [Related]
20. Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing. Podolski-Renić A; Jadranin M; Stanković T; Banković J; Stojković S; Chiourea M; Aljančić I; Vajs V; Tešević V; Ruždijić S; Gagos S; Tanić N; Pešić M Cancer Chemother Pharmacol; 2013 Sep; 72(3):683-97. PubMed ID: 23934261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]